It is interesting what is going on, I, like many, have been in this @$.30 for a long time so a drop to $2.80 really does not phase me. I would think this is more of a desperate time for shorts, they know soon is an uplisting, Eua’s etc... there are many shorts that started short in at $3 and they had to get out. There are also many new investors that got in in the last few months and are not as solid in the science of this drug. I’m not worried and I think this turbulence is all part of the process.

As for som BP power trying to smother us, they can do their best and ruin a stock price, but leronlimab works and there is enough cash in the bank to survive this.